AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹13 Cr | ₹-5.30 Cr | ₹-17 Cr | ₹5.08 Cr | ₹10 Cr |
What is the latest Cash Flow from Investing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹-5.30 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹5.08 Cr |
| Mar2021 | ₹10 Cr |
How is Cash Flow from Investing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | Positive | |
| Mar2024 | ₹-5.30 Cr | Negative | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹5.08 Cr | -49.68 | |
| Mar2021 | ₹10 Cr | - | |
Compare Cash Flow from Investing Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹210.3 Cr | -4.1% | 2.2% | -51% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -4.1% |
2.2% |
-51% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses